Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exicure Inc (XCUR)
NASDAQ:XCUR
Holding XCUR?
Track your performance easily
XCUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.44 - $36.00
Previous CloseN/A
Volume39.94K
Average Volume (3M)143.14K
Market Cap
$31.32M
Enterprise Value$12.38M
Total Cash (Recent Filing)$19.62M
Total Debt (Recent Filing)$4.45M
Price to Earnings (P/E)―
Beta2.81
Next Earnings
Mar 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.26
Shares Outstanding2,605,701
10 Day Avg. Volume219,298
30 Day Avg. Volume143,144
Standard Deviation1.16
R-Squared0.03
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)18.64
Price to Cash Flow (P/CF)-14.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue14.54
Enterprise Value/Gross Profit22.50
Enterprise Value/Ebitda-3.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Exicure News
PremiumCompany Announcements
Exicure Secures $8.7 Million in Stock Purchase Deal
PremiumCompany Announcements
Exicure Shareholders Approve Major HiTron Equity FinancingOwnership Overview
32.60% Insiders
0.73% Mutual Funds
2.16% Other Institutional Investors
64.20% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
XCUR FAQ
What was Exicure Inc’s price range in the past 12 months?
Exicure Inc lowest stock price was $1.44 and its highest was $36.00 in the past 12 months.
What is Exicure Inc’s market cap?
Exicure Inc’s market cap is $31.32M.
When is Exicure Inc’s upcoming earnings report date?
Exicure Inc’s upcoming earnings report date is Mar 06, 2025 which is in 33 days.
How were Exicure Inc’s earnings last quarter?
Exicure Inc released its earnings results on Nov 14, 2024. The company reported -$0.574 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.574.
Is Exicure Inc overvalued?
According to Wall Street analysts Exicure Inc’s price is currently Overvalued.
Does Exicure Inc pay dividends?
Exicure Inc does not currently pay dividends.
What is Exicure Inc’s EPS estimate?
Exicure Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exicure Inc have?
Exicure Inc has 2,605,701 shares outstanding.
What happened to Exicure Inc’s price movement after its last earnings report?
Exicure Inc reported an EPS of -$0.574 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.805%.
Which hedge fund is a major shareholder of Exicure Inc?
Currently, no hedge funds are holding shares in XCUR
---
Exicure Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 22.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.1%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
329.13%
12-Months-Change
Fundamentals
Return on Equity
-259.35%
Trailing 12-Months
Asset Growth
-17.91%
Trailing 12-Months
Company Description
Exicure Inc
Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
---
Technical Analysis
Alnylam Pharma
―
Arrowhead Pharmaceuticals
―
Ionis Pharmaceuticals
―
Sorrento Therapeutics
―
Moderna
―
---